Fundamentals of Chemotherapy Immunotherapy Administration Practice Test

Monitoring for signs of autoimmune reactions is crucial for patients receiving certain immunotherapies due to the mechanism of action of these treatments. Immunotherapies, such as checkpoint inhibitors, work by enhancing the body's immune response against cancer cells. However, this heightened immune activity can sometimes lead to the immune system attacking not only cancer cells but also healthy tissues, resulting in autoimmune reactions.

These reactions can manifest in various ways, affecting multiple organ systems, including the skin, gastrointestinal tract, liver, and endocrine glands. Patients may develop conditions such as colitis, dermatitis, hepatitis, or even endocrinopathies. Therefore, early recognition and management of autoimmune effects are essential to mitigate severe and potentially life-threatening complications associated with immunotherapy.

While monitoring blood pressure or dietary intake might be important in the context of overall patient health or other treatments, they do not specifically address the unique risks posed by immunotherapy. Additionally, while monitoring kidney function may be relevant, it is not the exclusive concern, as the wider spectrum of autoimmune reactions needs to be closely followed.

In summary, vigilant monitoring for signs of autoimmune reactions is paramount in the management of patients undergoing immunotherapy, aligning with the nature of these treatments and their potential side effects.